Genes
NCBI Gene
One gene with its proteins, patents, drugs, trials, grants and papers.
ConductScience Library
No account needed
One record for each drug in Open Targets 26.09 that acts on a target, is paired with a disease or is named by a trial. Each joins the drug to the targets ChEMBL's mechanism records give it, the diseases Open Targets pairs it with, each with its stage and the sources of that stage, and the ClinicalTrials.gov trials whose record names it, with the comparisons, papers and cognitive tests of those trials. Posted results are those in CTTI's AACT copy of 23 Mar 2026.
A drug's name, brand name or code, or its ChEMBL ID; a target's symbol or Ensembl ID; or a disease's name or ID. Case and punctuation do not matter. Other words find the drugs whose names hold every one or, when none does, the targets and diseases whose names do.
12,618 drugs from Open Targets.
Try searching
Most trials with posted results first1 to 20 of 12,618
| Drug | ChEMBL ID | Trials | With posted results | Targets | Diseases |
|---|---|---|---|---|---|
| CYCLOPHOSPHAMIDE Cytoxan, Cytoxan (lyophilized), Endoxana, Lyophilized cytoxan, Neosar | CHEMBL1200796 Small molecule | 3,516 | 917 | 0 | 423 |
| PACLITAXEL Abraxane, Apealea, Apexelsin, Naveruclif, Pacitaxel, Paclitaxel component of abi 007, Paclitaxel component of abraxane, Paclitaxel component of nab-, Paclitaxel component of oraxol, Paxene, Pazenir, Taxol, Taxol 100, Zisu | CHEMBL428647 Small molecule | 3,691 | 893 | 15 | 266 |
| BEVACIZUMAB Abevmy, Alymsys, Avastin, Avzivi, Aybintio, Equidacent, Lextemy, Mvasi, Onbevzi, Oyavas, Vegzelma, Zirabev | CHEMBL1201583 Antibody | 2,643 | 762 | 1 | 273 |
| CARBOPLATIN Paraplatin | CHEMBL1351 Small molecule | 3,013 | 752 | 0 | 283 |
| DEXAMETHASONE Aeroseb-dex, Decaderm, Decadron, Decadron-75, Decaspray, Dexa-sine, Dexacortal, Dexacortin, Dexacortisyl, Dexafree, Dexamethasone component of ciprodex, Dexamethasone component of dexacidin, Dexamethasone component of dexasporin, Dexamethasone component of maxitrol, Dexamethasone component of tobradex, Dexamethasone component of tobradex st, Dexamethasone intensol, Dexamonozon, Dexapos, Dexasite, Dexasone, Dexone, Dexone 0.5, Dexone 0.75, Dexone 1.5, Dexone 4, Dexsol, Dextenza, Dexycu kit, Dropodex, Fortecortin, Gppe ear spy, Hemady, Hexadrol, Isopto-dex, Kortico injection, Loverine, Luxazone, Martapan, Maxidex, Maxitrol, Oradexon, Otomize, Ozurdex, Sofradex, Spersadex comp, Tobradex | CHEMBL384467 Small molecule | 3,105 | 734 | 1 | 445 |
| PEMBROLIZUMAB Keytruda, Pembrolizumab component of mk 7684a, Pembrolizumab component of mk-1308a | CHEMBL3137343 Antibody | 2,518 | 729 | 1 | 261 |
| RITUXIMAB Blitzima, Mabthera, Mabthera rituxan, Ritemvia, Rituxan, Rituximab component of rituxan hycela, Rituzena (previously tuxella), Rixathon, Riximyo, Ruxience, Truxima | CHEMBL1201576 Antibody | 2,250 | 688 | 1 | 219 |
| CISPLATIN Platinol, Platinol-aq | CHEMBL11359 Small molecule | 3,441 | 667 | 0 | 296 |
| GEMCITABINE Gemzar | CHEMBL888 Small molecule | 2,544 | 546 | 14 | 199 |
| DOCETAXEL Beizray, Docetaxel accord, Docetaxel teva, Docetaxel zentiva (previously docetaxel winthrop), Docivyx, Taxceus, Taxespira (previously docetaxel hospira uk limited ), Taxotere | CHEMBL3545252 Small molecule | 2,251 | 533 | 15 | 171 |
| NIVOLUMAB Nivolumab bms, Nivolumab component of bms-986213, Nivolumab component of opdualag, Opdivo | CHEMBL2108738 Antibody | 1,726 | 491 | 1 | 280 |
| FLUOROURACIL 5.f.u., Accusite, Actikerall, Adrucil, Carac, Efudex, Efudix, Fluoro-uracil roche, Fluoroplex, Fluorouracil component of folfox, Tolak | CHEMBL185 Small molecule | 2,360 | 438 | 1 | 190 |
| METFORMIN | CHEMBL1431 Small molecule | 1,918 | 431 | 51 | 247 |
| PREDNISONE Cortan, Cortancyl, Decortisyl, Delta-dome, Deltasone, Fernisone, Liquid pred, Lodotra, Meticorten, Orasone, Paracort, Prednicen-m, Prednisone intensol, Rayos, Servisone, Sterapred | CHEMBL635 Small molecule | 1,416 | 402 | 1 | 370 |
| RIBAVIRIN Copegus, Cotronak, Rebetol, Ribapak, Ribasphere, Ribavarin, Ribavirin biopartners, Ribavirin mylan (previously ribavirin three rivers), Ribavirin teva, Ribavirin teva pharma b.v., Ribofluranosyl carboxamide, Viramid, Virazid, Virazole | CHEMBL1643 Small molecule | 859 | 398 | 1 | 45 |
| BUPIVACAINE Anekain, Bupivacaine component of zynrelef, Exparel, Exparel liposomal, Posimir | CHEMBL1098 Small molecule | 1,906 | 385 | 1 | 100 |
| METHOTREXATE Ebetrex, Emtexate high-pot, Emtexate pf, Jylamvo, Maxtrex, Metoject, Nordimet, Otrexup, Otrexup pfs, Rasuvo, Reditrex, Zlatal | CHEMBL34259 Small molecule | 1,373 | 381 | 1 | 258 |
| CAPECITABINE Capecitabine accord, Capecitabine component of xeliri capecitibine, Capecitabine component of xelox, Capecitabine medac, Capecitabine sun, Capecitabine teva, Ecansya (previously capecitabine krka), Xeloda | CHEMBL1773 Small molecule | 2,080 | 374 | 1 | 139 |
| OXALIPLATIN Eloxatin, Oxaliplatin component of folfox, Oxaliplatin component of xelox | CHEMBL414804 Small molecule | 2,306 | 368 | 0 | 157 |
| LENALIDOMIDE Lenalidomide accord, Lenalidomide mylan, Revlimid | CHEMBL848 Small molecule | 1,117 | 367 | 8 | 133 |
Code
curl "https://conductscience.org/api/drugs/v1"
Response
The first 2 of this page's 20 results. GET /api/drugs/v1
{
"data": {
"total": 12618,
"results": [
{
"id": "CHEMBL1200796",
"title": "CYCLOPHOSPHAMIDE",
"name": "CYCLOPHOSPHAMIDE",
"summary": "Small molecule, CHEMBL1200796. 3,516 trials, 917 with posted results.",
"record": "/library/drugs/CHEMBL1200796",
"drug_type": "Small molecule",
"brands": "Cytoxan, Cytoxan (lyophilized), Endoxana, Lyophilized cytoxan, Neosar",
"counts": {
"trials": 3516,
"trials_with_results": 917,
"targets": 0,
"diseases": 423,
"comparisons": 686,
"papers": 2248,
"tests": 19
}
},
{
"id": "CHEMBL428647",
"title": "PACLITAXEL",
"name": "PACLITAXEL",
"summary": "Small molecule, CHEMBL428647. 3,691 trials, 893 with posted results.",
"record": "/library/drugs/CHEMBL428647",
"drug_type": "Small molecule",
"brands": "Abraxane, Apealea, Apexelsin, Naveruclif, Pacitaxel, Paclitaxel component of abi 007, Paclitaxel component of abraxane, Paclitaxel component of nab-, Paclitaxel component of oraxol, Paxene, Pazenir, Taxol, Taxol 100, Zisu",
"counts": {
"trials": 3691,
"trials_with_results": 893,
"targets": 15,
"diseases": 266,
"comparisons": 637,
"papers": 1975,
"tests": 1
}
}
],
"columns": [
{
"key": "name",
"label": "Drug",
"under": "brands"
},
{
"key": "id",
"label": "ChEMBL ID",
"under": "drug_type"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.trials_with_results",
"label": "With posted results"
},
{
"key": "counts.targets",
"label": "Targets"
},
{
"key": "counts.diseases",
"label": "Diseases"
}
],
"order": "Most trials with posted results first",
"kinds": {
"all": 12618,
"with-results": 5231
}
},
"release": "pipelines-2026-09-18-0.3.1",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ConductCognition's list of its tests",
"license": "Our own data: ConductCognition's list of its tests, https://conductcognition.com",
"notice": null,
"short": "Our own data"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "No license stated"
},
{
"source": "NLM's MeSH",
"license": "NLM's",
"notice": null,
"short": "NLM's terms"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubMed",
"license": "NLM's terms",
"notice": null,
"short": "NLM's terms"
}
],
"next": "/api/drugs/v1?page=2",
"request_id": "AKg8V3lHmi6EYqZg"
}The 6 lists in a drug's record, and how many drugs have each.
The targets ChEMBL's mechanism records give for the drug, through Open Targets. A mechanism record says what the drug acts on, not how strongly.
5,05240.0% of drugs
The diseases Open Targets' clinical reports study the drug for, the most trial reports first. The stage is Open Targets', the highest any of its sources reports for the pair, and each row names the sources that report it.
11,37890.2% of drugs
Trials whose record names the drug by a name ChEMBL states, posted results first, then the largest. Open Targets read each trial's text to find its drugs.
9,27573.5% of drugs
Comparisons Trial comparisons calculated in the trials whose record names the drug, most participants first. A comparison in one of its trials does not always compare the drug, so read the two groups.
3,47127.5% of drugs
The papers the trials whose record names the drug list on ClinicalTrials.gov as their results (RESULT) or as drawn from them (DERIVED), results first, newest first.
5,96647.3% of drugs
The tests ConductCognition runs that the trials whose record names the drug name in their registered outcomes, as ScienceGraph matched them. ConductCognition's list names the tests it runs, not every test a trial used.
8877.0% of drugs
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NCBI Gene
One gene with its proteins, patents, drugs, trials, grants and papers.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/drugs/v1. No key.
GET https://conductscience.org/api/drugs/v1?q=Repatha
Ask an assistant